Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

159.13 +7.40 (+4.88%)
Streaming Delayed Price Updated: 11:43 AM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Circle's Blockbuster Success Aside, Tether CEO Doesn't Want To Go Public: 'Not Trying To Please' Couple Of JPMorgan Analysts
Paolo Ardoino, CEO of stablecoin issuer Tether (CRYPTO: USDT), said Thursday that the company has no plans to go public, despite Circle Internet Financial’s (NYSE:CRL) success on Wall Street. 
Via Benzinga
Senate Passes GENIUS Act—Coinbase's Brian Armstrong Calls It 'Big Milestone,' Scott Bessent Says Passage Could Drive Stablecoins Into A $3.7 Trillion Market
In a significant development, the Senate passed the GENIUS Act on Tuesday, a bill establishing the country’s first regulatory framework for dollar-pegged stablecoins. 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill
3 Unpopular Stocks in Hot Water
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
From Charles River Laboratories International, Inc.
Via Business Wire
Shopify Teams Up With Coinbase, Stripe To Roll Out USDC Stablecoin Payments For Merchants
Tobi Lütke, CEO of Shopify Inc. (NASDAQ:SHOP), said Thursday that the firm has partnered with Coinbase Global Inc. (NASDAQ:COIN) to integrate USD Coin (CRYPTO: 
Via Benzinga
CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook
Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2.7% year on year to $984.2 million. Its non-GAAP... 
Via StockStory
Topics Animal Testing
Circle Stock Has Popped 271% Since NYSE Debut, Now A KPMG Consultant Says This Is The Next Big Thing After Stablecoins
Tarun Anand, KPMG’s Blockchain and Digital Asset Consultant, said stablecoins, real-world asset tokenization and decentralized physical infrastructure networks will be the key cryptocurrency narratives... 
Via Benzinga
Circle IPO Success Suggests Markets Open To New Listings, Especially From Crypto Businesses, Says SPAC King Chamath Palihapitiya
Venture capitalist Chamath Palihapitiya admired Circle Internet Group’s (NYSE:CRL) successful Wall Street debut on Monday, suggesting it could pave the way for more cryptocurrency companies to enter... 
Via Benzinga
Topics Initial Public Offering
Crypto At 'Point Of No Return,' Says Fireblocks CEO And Here's Why He Is Confident About It
Michael Shaulov, CEO of digital asset infrastructure provider Fireblocks, asserted that cryptocurrency has crossed the “point of no return,” with increasing acceptance and impending regulation... 
Via Benzinga
Ex-Goldman Executive On Circle's 168% IPO Spike: Don't Rush To Buy Stock As Bankers Engineer A 'Pop' — Cites Facebook Example
Ex-Goldman Executive On Circle's 168% IPO Spike: Don't Rush To Buy Stock As Bankers Engineer A ‘Pop' — Cites Facebook Example 
Via Benzinga
Topics Initial Public Offering
1 Safe-and-Steady Stock Worth Your Attention and 2 to Steer Clear Of
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Wednesday's session: top gainers and losers in the S&P500 index
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill
Which S&P500 stocks are moving on Wednesday?
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
These S&P500 stocks are moving in today's pre-market session
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
Charles River Laboratories to Present at William Blair and Jefferies Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
From Charles River Laboratories International, Inc.
Via Business Wire
This Waste Management Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that... 
Via StockStory
Topics Bonds Stocks
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Charles River Laboratories (NYSE:CRL) and its peers. 
Via StockStory
Charles River Laboratories to Present at Bank of America Health Care Conference
From Charles River Laboratories International, Inc.
Via Business Wire
What 10 Analyst Ratings Have To Say About Charles River
Via Benzinga
Charles River Labs Stock Soars On Strategic Review Plan With Elliott: Retail Investors Optimistic
The review aims to enhance shareholder value, with four new independent directors joining the board. Despite a 2.7% drop in Q1 revenue, analysts raised their outlook, boosting retail sentiment. 
Via Stocktwits
Top S&P500 movers in Wednesday's session
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Why Are Charles River Laboratories (CRL) Shares Soaring Today
Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 17.3% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat... 
Via StockStory
Topics Artificial Intelligence
Unusual volume S&P500 stocks in Wednesday's session
Let's have a look at the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization
Charles River shares rise after Q1 adjusted EPS and revenue top estimates; company raises 2025 outlook and adds four directors to its board. 
Via Benzinga
Topics Earnings
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Rockwell Automation Posts Better-Than-Expected Earnings, Joins Oscar Health, Charles River Laboratories, Walt Disney, Voya Financial And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.